Home › Upcoming votes › TherapeuticsMD, Inc.
Prior-year votes at TherapeuticsMD, Inc. →
Read the proxy statement on EDGARTherapeuticsMD, Inc.: past votes
Ballot read from the proxy statement and checked. As listed in TherapeuticsMD, Inc.’s proxy statement, with the board’s recommendation on each item. The company has filed 1 set of additional materials since; they can add to or change what is below, so check them before relying on it.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | Election of Directors Director election |
Board | For | 4 nominees; support 98% to 99.5% |
| 2 | Advisory Vote on Executive Compensation ("Say-on-Pay") Say on pay |
Board | For | 98% support |
| 3 | Ratification of Appointment of Independent Auditor Auditor |
Board | For | 99.4% support |
From TherapeuticsMD, Inc.’s Form 8-K, filed December 16, 2025, for the meeting held December 15, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Tommy G. Thompson | 99.2% | Elected |
| Elect Director: Cooper C. Collins | 99% | Elected |
| Elect Director: Gail K. Naughton, Ph.D. | 99.5% | Elected |
| Elect Director: Justin Roberts | 98% | Elected |
| 2. On a non-binding advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2024 | 98% | Approved |
| 4. The appointment of Berkowitz Pollack Brant Advisors + CPAs, LLP, an independent registered public accounting firm, as the independent… | 99.4% | Approved |
| 5. An amendment to our Amended and Restated Articles of Incorporation, as amended, to increase the number of authorized shares of common… | 92% | Approved |
The five managers that reported the most shares voted at TherapeuticsMD, Inc.’s December 15, 2025 meeting, from their Form N-PX filings. This is how they voted then; it says nothing about how they will vote this time. Every manager’s vote.
| Item | Rubric Capital Management LP | Clearline Capital LP | Vanguard | ADAR1 Capital Management, LLC | GEODE CAPITAL MANAGEMENT, LLC |
|---|---|---|---|---|---|
| Elect Director: Tommy G. Thompson | — | — | For | — | — |
| Elect Director: Cooper C. Collins | — | — | For | — | — |
| Elect Director: Gail K. Naughton, Ph.D. | — | — | For | — | — |
| Elect Director: Justin Roberts | — | — | For | — | — |
| 2. On a non-binding advisory basis, the compensation of the Company's named executive officers for the fiscal year… | For | For | For | For | For |
| 4. The appointment of Berkowitz Pollack Brant Advisors + CPAs, LLP, an independent registered public accounting firm… | — | — | For | — | — |
| 5. An amendment to our Amended and Restated Articles of Incorporation, as amended, to increase the number of… | — | — | For | — | — |
| To provide a non-binding advisory vote on the frequency of future non-binding advisory votes on the compensation of our | -- | -- | -- | -- | -- |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.